HORIZON-JU-IHI-2023-04-04-two-stage
HORIZON-JU-IHI-2023-04-04-two-stage
Programme: Horizon Europe
1 project · €8,500,000 total EU contribution (project-level) · 52 participating organizations · 13 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€8,500,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (9)
- France (8)
- BE (6)
- Spain (5)
- Netherlands (5)
- US (5)
- Italy (4)
- AT (3)
- CH (2)
- UK (2)
- AR (1)
- DK (1)
- NO (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ALEXION PHARMACEUTICALS INC1 projects · US
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- ASTRAZENECA UK LIMITED1 projects · UK
- AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE1 projects · IT
- BAYER AKTIENGESELLSCHAFT1 projects · DE
- BAYER PUBLIC LIMITED COMPANY1 projects · UK
- BII GMBH1 projects · DE
- BI PHARMA GMBH1 projects · DE
- CONECT4CHILDREN STICHTING1 projects · NL
- C-PATH1 projects · NL
- EATRIS1 projects · NL
- EURORDIS - RARE DISEASES EUROPE1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases RealiseD · 101165912 | HORIZON | €8,500,000 | €320,921 | Details |